Spyre Therapeutics Inc (SYRE)

Other Income/Expenses (Net)

$22.42M

TTM · Period ending: · USD

SYRE logo

SYRE Other Income/Expenses (Net)

Latest reported$22.42M
SYRE TTM Other Income/Expenses (Net) (-$1.44M → $22.42M)
High-resolution chart · PNG

SYRE other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Spyre Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
22,422,000
22,201,000
54,344,000
64,660,000
5,337,000
5,429,000
599,000
-21,625,000
-29,774,000
-92,912,000
-96,513,000
-78,869,000
-56,790,000
1,147,000
804,000
445,000
145,000
3,000
-11,000
32,000
110,000
285,000
588,000
940,000
1,423,000
1,884,000
2,080,000
2,073,000
1,826,000
1,479,000
1,115,000
851,000
649,000
481,000
439,000
356,000
295,000
272,000
208,000
158,000
99,000
39,000
20,000
10,000
-104,000
-779,000
-1,443,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.